Checklist prior to recruiting first patient

Similar documents
GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

Good Documentation Practices. Human Subject Research. for

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

Document Title: Study Data SOP (CRFs and Source Data)

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

STH Researcher. Recording of research information in patient case notes

Standard Operating Procedure (SOP) Research and Development Office

The GCP Perspective on Study Monitoring

Trial Management: Trial Master Files and Investigator Site Files

Clinical Trial Quality Assurance Common Findings

VCU Clinical Research Quality Assurance Assessment

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

Essential Documents It s Not Just a Binder!

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Investigator Site File Standard Operating Procedure (SOP)

WIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Unofficial copy not valid

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Good Clinical Practice: A Ground Level View

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Document Title: Investigator Site File. Document Number: 019

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

1. INTRODUCTION 2. SCOPE 3. PROCESS

Storage and Archiving of Research Documents SOP 6

Subject Research Records. Essential Regulatory and Source Documents. Subject Research Records. Regulatory Files

Clinical Trial Readiness Checklist October 2014

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

QUALITY ASSURANCE PROGRAM

EMA Inspection Site perspective

RITAZAREM CRF Completion Guidelines

Standard Operating Procedure (SOP)

FDA Medical Device Regulations vs. ISO 14155

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

Site Closedown Checklist for UoL Sponsored CTIMP Studies

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

STANDARD OPERATING PROCEDURE SOP 325

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

Monitoring Clinical Trials

FDA Inspection Readiness

managing or activities.

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Conducting Monitoring Visits for Investigator-Initiated Trials (IITs)

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Clinical Study Risk Assessment

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Overview ICH GCP E6(R2) Integrated Addendum

GCP INSPECTION CHECKLIST

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Document Title: Informed Consent for Research Studies

Inspections, Compliance, Enforcement, and Criminal Investigations

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

Quality Assurance and Site Monitoring Visits. Introduction. Training Outline

BIMO SITE AUDIT CHECKLIST

Standard Operating Procedures

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

Standard Operating Procedure (SOP) Research and Development Office

Effective Date: 11/09 Policy Chronicle:

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

STANDARD OPERATING PROCEDURE

Research Staff Training

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

Study Monitoring Plan Template

Successful FDA Inspections at Investigative Sites for Clinical Trials of Drugs and Biologics

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

STANDARD OPERATING PROCEDURE

Quality and Informed Consent Procedures

20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Setting up a Clinical Trial

Standard Operating Procedures (SOP) Research and Development Office

STANDARD OPERATING PROCEDURE

COMPETENCY FRAMEWORK

Roles & Responsibilities of Investigator & IRB

Transcription:

Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF

Checklist prior to recruiting first patient Item Document Requirement Tick 1. Pharmacy green light Ensure document sent from pharmacy. Save a copy in the study folder 2. R&D NHS approval letter Ensure letter saved in study folder (attach to study live email) 3. Study folder Move from in-set-up to open studies 4. Study folder Check all documents (protocols) PIS are the most up-to-date versions and any earlier copies are in the superceded folder 5. SLA s Check all SLA s (if applicable) are in place and include the contact details are in the study live email 6. CRF Manager Check study has been added to CRF manager 7. Edge If NIHR adopted study is it on EDGE? 8. Worksheets Have the woksheets been completed and approved by relevant parties?

Recruitment issues Consent issues Screening (contact card) Data capture (source worksheets, examples)

Administration of IMP Route of administration of IMP Things to consider prior to administration Pharmacy manual IMP prescription-electronic or trial specific IVRS Pharmacy specific worksheets Drug accountability/compliance Diary cards

Sampling Work sheets PK PD Biopsies processing Storage Shipping

Monitoring What to expect in a monitoring visit Book a time/space How to book out notes etc Who contacts who Follow-up on monitoring letters QUALITY & GOVERNANCE

QUALITY & GOVERNANCE Source data and documentation Audits Inspections Reports CAPA (deadlines) Violation Deviation Delegation /training logs

Documentation in clinical trials: Essential Documents Are those documents, which permit evaluation of the conduct of the trial and the quality of data produced. These documents serve to demonstrate the compliance of the investigator, sponsor and monitor with the standards of GCP and with all regulatory requirements ICH (8.1)

Documentation in clinical trials: essential documents Are audited by the regulatory authorities or sponsor to confirm the validity and integrity of the data collected Are contained in the files established at the beginning of the trial at both sponsor and investigator site For the minimum list - see ICH section 8 10

What needs to be recorded in the patient notes? Copy of signed and dated Consent Form and Patient Information Sheet Title of the trial including the drug to be received Local and trial specific numbers Visit dates Concomitant medications Adverse events A letter informing the GP that the patient has been enrolled in the clinical trial 11

Essential Documents availability Essential documents should be retained for 2 yrs following last approval of marketing application in the ICH region (taken to be 15yrs) ICH (4.9.5) All records must be made available (direct access) for monitors, auditors & regulatory authorities ICH (4.9.7) 12

Subject level documentation requirements: Subject specific documentation Attributable The author and content should be clear Legible Capable of being read In a human-readable format Changes don t obscure original entry Print name if signature is illegible 13

Subject Specific Documentation Contemporaneous The notation, signature, and date need to be completed at the same time and as close to the event as possible Original First recording of the information (paper, electronic) Accurate Errors have been identified and corrected 14

Corrections to Documentation Proper Notation of Corrections: One line strike through, write new data, initial, date and explain (if necessary) Unacceptable: Obliteration, correction fluid, write overs New information must not obliterate previous information Erasing/Recording in pencil Exceptions Do Not edit subject s personal writings 15

Source Data All information in original records and certified copies of original records of clinical findings, observations or other activities in a clinical trial necessary for the reconstruction and evaluation of the study. 16

Source Data and Documentation Source Data provides: The reconstruction and evaluation of the study Confirmation of subject existence and observations Substantiation of study data integrity Source Documents: All information in original records and certified copies of original records (ICH GCP 1.51) Include: Clinical findings, Observations, and Other study activities The first time data is captured: paper towel, report, log, database 17

Examples of Source Documents A record which contains ORIGINAL data in the format and medium it was captured: Medical records Lab reports X-rays, ECGs Intake/Screening forms Telephone contact records, faxes, e-mails Subject diaries Informed consent forms Drug prescription records 18

Importance of Documentation Over the past 5 years, 25-30% of all warning letters from the FDA to Investigators were related to inadequate/inaccurate records This is the 2nd most sited deficiency in the country (Duke Medicine) 19

Examples of cited issues Unscheduled visits not documented Phone follow-up not documented Lack of medical history files Retrospective handwritten annotations without dates Discrepancies between clinic notes, clinic visit forms, source document worksheets and CRFs 20

Source Documentation: In Summary If it happened document it! If it was supposed to happen and didn t, document and explain! Be thorough and timely in your documentation Quality checks periodically during study and before archiving If you find documentation errors, be pro-active and file a deviation/file note and activate a corrective action plan 21